Dana Farber/Harvard Cancer Center

Latest stories

23d
News-Medical-Net
Overweight kidney cancer patients live longer than normal-weight counterparts, study showsObesity almost always increases cancer risk and worsens outcomes, but researche
Overweight kidney cancer patients live longer than normal-weight counterparts, study shows
News-Medical-Net / Posted 23 days ago
Obesity almost always increases cancer risk and worsens outcomes, but researchers led by scientists at Dana-Farber Cancer Institute report that overweight patients with advanced kidney cancer had significantly longer survival than those who were... Read more
2 related stories
23d
Boston Herald
Construction worker dies in crane accidentA construction worker was killed while aboard a crane that was being disassembl
Construction worker dies in crane accident
Boston Herald / Posted 23 days ago
A construction worker was killed while aboard a crane that was being disassembled in the Longwood Medical Area yesterday, authorities said. “They were disassembling a crane — he was on it,” said Boston Fire Department spokesman Steve... Read more
24d
Bel Marra Health
Prostate Cancer and Health Awareness Month: Parkinson’s disease, Alzheimer’s disease, heart failure, heart attack, blood pressure, and circumcisionSeptember is Prostate Cancer and Health Awareness Month, so we present some of
Prostate Cancer and Health Awareness Month: Parkinson’s disease, Alzheimer’s disease, heart failure, heart attack, blood pressure, and circumcision
Bel Marra Health / Posted 24 days ago
September is Prostate Cancer and Health Awareness Month, so we present some of our stories discussing prostate cancer, as well as conditions that can affect prostate health, including Parkinson’s disease, Alzheimer’s disease, heart failure, heart... Read more
26d
Business Wire
C4 Therapeutics Completes Core Scientific Leadership Team to Accelerate the Discovery of Novel Therapeutics for Targeted Protein DegradationCAMBRIDGE, Mass.--(BUSINESS WIRE)--C4 Therapeutics (C4T) today announced detail
C4 Therapeutics Completes Core Scientific Leadership Team to Accelerate the Discovery of Novel Therapeutics for Targeted Protein Degradation
Business Wire / Posted 26 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--C4 Therapeutics (C4T) today announced details of the leadership team recruited to develop a new class of broadly applicable small molecule drugs for degrading disease-relevant proteins for therapeutic benefit. The... Read more

People in this news